{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:06:46Z","timestamp":1789852006075,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR003981"],"award-info":[{"award-number":["KL2TR003981"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R21HL168496-01"],"award-info":[{"award-number":["R21HL168496-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R38HL150214"],"award-info":[{"award-number":["R38HL150214"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xkme.2026.101435","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:54:20Z","timestamp":1781542460000},"page":"101435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"8","author":[{"given":"Bethany","family":"Roehm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Haley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Grodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Susan","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xkme.2026.101435_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jchf.2024.11.007","article-title":"Outcomes of KDIGO-defined CKD in U.S. veterans with HFpEF, HFmrEF, and HFrEF","volume":"13","author":"Patel","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"19","key":"10.1016\/j.xkme.2026.101435_bib2","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101435_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.ajkd.2023.03.005","article-title":"The difference between cystatin C- and creatinine-based eGFR in heart failure with reduced ejection fraction: insights from PARADIGM-HF","volume":"82","author":"Pinsino","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"10.1016\/j.xkme.2026.101435_bib4","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.2025.17578","article-title":"Discordance in creatinine- and cystatin C-based eGFR and clinical outcomes: a meta-analysis","volume":"334","author":"Estrella","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.xkme.2026.101435_bib5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12872-024-04359-z","article-title":"Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.xkme.2026.101435_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.34067\/KID.0000000000000384","article-title":"Association of ratio of eGFR by cystatin C and creatinine with mortality in heart failure","volume":"5","author":"Roehm","year":"2024","journal-title":"Kidney360"},{"issue":"9","key":"10.1016\/j.xkme.2026.101435_bib7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/eurjpc\/zwaa117","article-title":"Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction","volume":"28","author":"Konishi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101435_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/clc.23970","article-title":"Prevalence of sarcopenia and its association with clinical outcomes in heart failure: an updated meta-analysis and systematic review","volume":"46","author":"Chen","year":"2023","journal-title":"Clin Cardiol"},{"issue":"15","key":"10.1016\/j.xkme.2026.101435_bib9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101435_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.xkme.2026.101435_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int"},{"issue":"17","key":"10.1016\/j.xkme.2026.101435_bib12","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMc1612601","article-title":"Spironolactone metabolites in TOPCAT\u2014new insights into regional variation","volume":"376","author":"de Denus","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101435_bib13","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1002\/ehf2.13975","article-title":"The difference between cystatin C- and creatinine-based assessment of kidney function in acute heart failure","volume":"9","author":"Pinsino","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.xkme.2026.101435_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.ajkd.2023.04.002","article-title":"Discordances between creatinine- and cystatin C-based estimated GFR and adverse clinical outcomes in routine clinical practice","volume":"82","author":"Carrero","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101435_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.ajkd.2025.03.018","article-title":"Complex etiologies of the discordance between cystatin C- and creatinine-based estimated GFR and its adverse associations: findings from the CRIC study","volume":"86","author":"McCoy","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2026.101435_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cardfail.2020.07.013","article-title":"Cystatin C and muscle mass in patients with heart failure","volume":"27","author":"Ivey-Miranda","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.xkme.2026.101435_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1671305","article-title":"Comparison of sarcopenia prevalence and prognostic features between HFrEF and HFpEF: a systematic review and meta-analysis","volume":"12","author":"Xiong","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.xkme.2026.101435_bib18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ejhf.2254","article-title":"Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction","volume":"23","author":"Sorimachi","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.xkme.2026.101435_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12902-024-01589-2","article-title":"Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology Registry","volume":"24","author":"Bae","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"10.1016\/j.xkme.2026.101435_bib20","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/oby.2009.96","article-title":"Potential contribution of adipose tissue to elevated serum cystatin C in human obesity","volume":"17","author":"Naour","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"10.1016\/j.xkme.2026.101435_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjmed.2008.01.040","article-title":"Is serum cystatin-C a reliable marker for metabolic syndrome?","volume":"121","author":"Servais","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.xkme.2026.101435_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2369-9-9","article-title":"Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"9","author":"Keller","year":"2008","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101435_bib23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2026.101435_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.xkme.2026.101435_bib25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1681\/ASN.0000000000000128","article-title":"Accuracy of GFR estimating equations in patients with discordances between creatinine and cystatin C-based estimations","volume":"34","author":"Fu","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"4S","key":"10.1016\/j.xkme.2026.101435_bib26","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2026.101435_bib27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ehf2.15128","article-title":"eGFR slope as predictor of mortality in heart failure patients","volume":"12","author":"Verstreken","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.xkme.2026.101435_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/j.ajkd.2025.01.011","article-title":"Association of estimated GFR slope and heart failure progression in older adults","volume":"85","author":"Kohansal","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2026.101435_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10741-024-10442-6","article-title":"BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis","volume":"30","author":"Ammar","year":"2025","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10.1016\/j.xkme.2026.101435_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jchf.2016.11.015","article-title":"Interaction between spironolactone and natriuretic peptides in patients with heart failure and preserved ejection fraction: from the TOPCAT trial","volume":"5","author":"Anand","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.xkme.2026.101435_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCHEARTFAILURE.111.962654","article-title":"Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial","volume":"4","author":"Anand","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.xkme.2026.101435_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jchf.2020.03.002","article-title":"Effects of Sacubitril\/Valsartan on N-terminal pro-B-type natriuretic peptide in heart failure with preserved ejection fraction","volume":"8","author":"Cunningham","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"24","key":"10.1016\/j.xkme.2026.101435_bib33","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/eurheartj\/ehad210","article-title":"Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial","volume":"44","author":"Tolomeo","year":"2023","journal-title":"Eur Heart J"}],"updated-by":[{"DOI":"10.1016\/j.xkme.2026.101483","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000}},{"DOI":"10.1016\/j.xkme.2026.101483","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:38:37Z","timestamp":1789850317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526001974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2590059526001974"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101435","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101435"}}